Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Wednesda...
15 Février 2018 - 10:05PM
Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) today announced that
it will host a webcast and conference call to discuss the Company’s
financial results for the fourth quarter and full year
ended December 31, 2017, and provide a general business
overview on Wednesday, February 28, 2018, at 4:30 p.m.
ET (1:30 p.m. PT).
Conference Call DetailsThe live
conference call on Wednesday, February 28, 2018, at 4:30
p.m. ET, can be accessed by phone by calling (844) 452-6828
from the United States and Canada or 1 (765)
507-2588 internationally and using the passcode 4893459. The
webcast can be accessed live on the Investor Relations section of
the Company's website at http://investors.portola.com. It will
be archived for 30 days following the call.
About Portola Pharmaceuticals,
Inc.Portola Pharmaceuticals is a biopharmaceutical
company developing product candidates that could significantly
advance the fields of thrombosis and other hematologic diseases.
The Company’s first medicine Bevyxxa® (betrixaban), an oral,
once-daily Factor Xa inhibitor, was approved by the U.S. Food
and Drug Administration in June 2017. The company is also
working to advance two clinical programs for andexanet alfa, a
recombinant protein designed to reverse the anticoagulant effect in
patients treated with an oral or injectable Factor Xa inhibitor;
and cerdulatinib, a SYK/JAK inhibitor in development to treat
hematologic cancers. Portola's partnered program is focused on
developing selective SYK inhibitors for inflammatory conditions.
For more information, visit http://www.portola.com and
follow the Company on Twitter @Portola_Pharma.
Investor Contact: Cara
MillerPortola Pharmaceuticalsir@portola.com
Media Contact:Laurie
MasonsonW2O Grouplmasonson@w2ogroup.com
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur